The Meeting

On June 9-10th we joined with other astronauts on our mission to get adolescent vaccination back on track.

Check out the full meeting recordings here and the individual presentations in the agenda below:

On our two-day journey, we

  • Explored the impacts of the COVID-19 pandemic on HPV vaccination and implications for progress towards Healthy People 2030
  • Charted a path towards health equity in HPV vaccination among diverse communities and understand the impact of other key determinants on adolescent vaccination rates
  • Learned valuable lessons from experts in overcoming real challenges to increase adolescent vaccination




DAY 1: June 9, 2021, 1:00 – 3:20 p.m. EST


1:00 p.m. LIFTOFF: Meeting Open

  • Dr. Kristin Oliver, Co-Chair, National HPV Vaccination Roundtable/American Academy of Pediatrics (AAP)
  • Dr. Rebecca Perkins, Co-Chair, National HPV Vaccination Roundtable/ American College of Obstetricians and Gynecologists (ACOG)

1:10 p.m. HPV Impact Story

1:15 p.m.  OPENING REMARKS: Transmitting the Importance of Adolescent Population Health

1: 25 p.m. FEATURED PRESENTATION: Reaching New Heights Together: A National Perspective from the Director of CDC’s Immunization Services & the Chief Medical Officer of Texas Children’s Pediatrics

Childhood immunization is down over 11 million doses due to pandemic health care disruptions.  Protecting children from vaccine-preventable diseases has never been more important.  Adolescent vaccine rates lag behind younger children, so we need to activate both the public and private sector to catch up for a safe return to in-person schooling this fall.  This session will provide an overview of childhood visits and immunization in the U.S. and describe the efforts of a pediatric health care system to prioritize HPV vaccination as cancer prevention before, during and after the pandemic.


2:15 p.m. PANEL PRESENTATION: There’s Space for Everybody: A Panel on HPV Vaccination in Diverse Communities

NASA’s twitter motto is “there’s space for everybody.” We believe this applies to vaccination as well. Every child should be fully protected from vaccine-preventable diseases. 

HPV vaccination rates for teens have traditionally been higher among communities of color than white populations thanks to strong public vaccination programs for children.  Due to pandemic disruptions, overall adolescent immunization rates have fallen 15-20%, with HPV vaccination down 19.2% as of late April 2021. Rates have fallen more among public vaccine recipients, which tend to serve more diverse populations.  Prior to the pandemic, males, rural teens and insured teens had lower vaccination rates.

This panel will present both recent research and insights from diverse organizations represented on the HPV Roundtable. This work represents efforts in Asian American, African American/Afro Caribbean, American Indian/Alaskan Native, and Latinx communities.



Suggested Pre-Reading:

3:15 p.m. Mission Control Check-In: Conclusion Remarks on Public Session


DAY 2: June 10, 2021, 12:00 – 2:50 p.m. EST

12:00 p.m. SHOOTING FOR THE MOON: Meeting Open

12:05 p.m. WELCOME

  • Kristin Oliver, Co-Chair, HPV Roundtable
  • Rebecca Perkins, Co-Chair, HPV Roundtable

12:10 p.m. PANEL PRESENTATION: The Atmosphere Matters: Current Data on Insurance and Geography as Determinants of HPV Vaccination

How do we take research on key HPV vaccination determinants and apply it for action at the state level?  This session will share recent research findings on effective interventions in rural communities and explore how immunization registries and geographic data mapping can target areas of low vaccination.  



Suggested Pre-Reading:

Bonus Background Materials:

1:00 p.m. HPV Survivor Impact Story

1:10 p.m. PANEL PRESENTATION:  Best and Promising Practices to Achieve New Heights in HPV Vaccination Rates: Start at Age 9 

Data continue to show the HPV vaccine is safe and effective, yet HPV vaccination rates remain well below national goals and other vaccines that are part of the “adolescent platform.” What can the evidence tell us about the potential benefits and challenges of routinely starting HPV vaccination at age nine? Would starting HPV vaccination at age nine increase HPV uptake and on-time completion? Are providers willing to recommend HPV vaccine at age nine and is it an easier interaction with parents when they do? What does this practice look like in an actual clinic? This panel will explore answers to these questions and more.  



Suggested Pre-Reading:

2:00 p.m. SPACE WALK

2:10 p.m. VaxTeen Video with Kelly Danielpour

2:15 p.m. PANEL PRESENTATION: Houston, We Made Contact with the AMGA Starship in the Asteroid Belt: Lessons from the HPV Best Practices Learning Collaborative

Eight health systems joined a national HPV learning collaborative launched in early 2020.  There were challenges, there were wins and there was commitment!  Hear from AMGA’s analytic and population health team members on lessons learned on adolescent vaccination and effective interventions during the pandemic. The data tells an impressive story you’ll want to see.


  • Dr. Elizabeth Ciemins, VP of Research & Analytics, AMGA
  • Cori Rattelman, Sr. Research Analyst, AMGA
  • Earlean Chambers, Director of Clinical and Quality Population Health Initiatives, AMGA


2:50 p.m. PUBLIC CLOSING REMARKS: Mission Command to Health Care